150 related articles for article (PubMed ID: 27895317)
41. High expression of IL-4R enhances proliferation and invasion of hepatocellular carcinoma cells.
Guo C; Ouyang Y; Cai J; Xiong L; Chen Y; Zeng X; Liu A
Int J Biol Markers; 2017 Oct; 32(4):e384-e390. PubMed ID: 28665449
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Int J Clin Exp Pathol; 2015; 8(5):4913-22. PubMed ID: 26191184
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
Zhao X; Dou W; He L; Liang S; Tie J; Liu C; Li T; Lu Y; Mo P; Shi Y; Wu K; Nie Y; Fan D
Oncogene; 2013 Mar; 32(11):1363-72. PubMed ID: 22614005
[TBL] [Abstract][Full Text] [Related]
44. Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p.
He T; Qi F; Jia L; Wang S; Wang C; Song N; Fu Y; Li L; Luo Y
Cancer Lett; 2015 Nov; 368(1):115-125. PubMed ID: 26272182
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
46. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
47. Arsenic trioxide inhibits breast cancer cell growth via microRNA-328/hERG pathway in MCF-7 cells.
Wang Y; Wang L; Yin C; An B; Hao Y; Wei T; Li L; Song G
Mol Med Rep; 2015 Jul; 12(1):1233-8. PubMed ID: 25824027
[TBL] [Abstract][Full Text] [Related]
48. Reprogramming carcinoma associated fibroblasts by AC1MMYR2 impedes tumor metastasis and improves chemotherapy efficacy.
Ren Y; Zhou X; Liu X; Jia HH; Zhao XH; Wang QX; Han L; Song X; Zhu ZY; Sun T; Jiao HX; Tian WP; Yang YQ; Zhao XL; Zhang L; Mei M; Kang CS
Cancer Lett; 2016 Apr; 374(1):96-106. PubMed ID: 26872723
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J
Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
[TBL] [Abstract][Full Text] [Related]
50. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
[TBL] [Abstract][Full Text] [Related]
51. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
[TBL] [Abstract][Full Text] [Related]
52. Targeting interleukin-4 receptor α with hybrid peptide for effective cancer therapy.
Yang L; Horibe T; Kohno M; Haramoto M; Ohara K; Puri RK; Kawakami K
Mol Cancer Ther; 2012 Jan; 11(1):235-43. PubMed ID: 22084165
[TBL] [Abstract][Full Text] [Related]
53. Commentary: IL-4 and IL-13 receptors and signaling.
McCormick SM; Heller NM
Cytokine; 2015 Sep; 75(1):38-50. PubMed ID: 26187331
[TBL] [Abstract][Full Text] [Related]
54. Association of IL4, IL13, and IL4R polymorphisms with gastrointestinal cancer risk: A meta-analysis.
Cho YA; Kim J
J Epidemiol; 2017 May; 27(5):215-220. PubMed ID: 28142034
[TBL] [Abstract][Full Text] [Related]
55. Differential Expression of ATM, NF-KB, PINK1 and Foxo3a in Radiation-Induced Basal Cell Carcinoma.
Jenni R; Chikhaoui A; Nabouli I; Zaouak A; Khanchel F; Hammami-Ghorbel H; Yacoub-Youssef H
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108343
[TBL] [Abstract][Full Text] [Related]
56. LncRNA CASC19 Enhances the Radioresistance of Nasopharyngeal Carcinoma by Regulating the miR-340-3p/FKBP5 Axis.
Liu H; Chen Q; Zheng W; Zhou Y; Bai Y; Pan Y; Zhang J; Shao C
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769373
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD-1 in Metastatic Non-Small Cell Lung Cancer.
He K; Barsoumian HB; Puebla-Osorio N; Hu Y; Sezen D; Wasley MD; Bertolet G; Zhang J; Leuschner C; Yang L; Kettlun Leyton CS; Fowlkes NW; Green MM; Hettrick L; Chen D; Masrorpour F; Gu M; Maazi H; Revenko AS; Cortez MA; Welsh JW
Cancer Immunol Res; 2023 Apr; 11(4):486-500. PubMed ID: 36700864
[TBL] [Abstract][Full Text] [Related]
58. Targeting miR-5088-5p attenuates radioresistance by suppressing Slug.
Seok HJ; Choi JY; Yi JM; Bae IH
Noncoding RNA Res; 2023 Jun; 8(2):164-173. PubMed ID: 36632615
[TBL] [Abstract][Full Text] [Related]
59. ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression.
Baldi S; Zhang Q; Zhang Z; Safi M; Khamgan H; Wu H; Zhang M; Qian Y; Gao Y; Shopit A; Al-Danakh A; Alradhi M; Al-Nusaif M; Zuo Y
J Cell Mol Med; 2022 Dec; 26(24):5984-5997. PubMed ID: 36420658
[TBL] [Abstract][Full Text] [Related]
60. The Assessment of Serum Cytokines in Oral Squamous Cell Carcinoma Patients: An Observational Prospective Controlled Study.
Caruntu A; Scheau C; Codrici E; Popescu ID; Calenic B; Caruntu C; Tanase C
J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36143043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
